Cargando…

Does the severity of the course of COVID-19 in pts without hospitalization and no history of cardiovascular disease affect of cardiac arrhythmias

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Many studies have shown that arrhythmias are an independent risk factor for death and the course of COVID-19 in these pts. However, there are no data on the impact of the SARS CoV-2 virus on pts with a domestic course of COVID-19 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chudzik, M, Babicki, M, Kapusta, J, Kolat, D, Kaluzinska-Kolat, Z, Mastalerz-Migas, A, Jankowski, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207495/
http://dx.doi.org/10.1093/europace/euad122.771
_version_ 1785046468018569216
author Chudzik, M
Babicki, M
Kapusta, J
Kolat, D
Kaluzinska-Kolat, Z
Mastalerz-Migas, A
Jankowski, P
author_facet Chudzik, M
Babicki, M
Kapusta, J
Kolat, D
Kaluzinska-Kolat, Z
Mastalerz-Migas, A
Jankowski, P
author_sort Chudzik, M
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Many studies have shown that arrhythmias are an independent risk factor for death and the course of COVID-19 in these pts. However, there are no data on the impact of the SARS CoV-2 virus on pts with a domestic course of COVID-19 without a previous history of cardiovascular disease. The aim of the study was to assess whether the severity of the home course of COVID-19 has an impact on cardiac arrhythmias in pts without previous cardiovascular disease. METHODS: The study included only pts after COVID-19 without hospitalization, without previous cardiovascular disease. Pts were divided into two groups depending on the severity of the COVID-19 course: Gr 1 with severe course of disease: symptoms lasting 7, dyspnoea lasting with oxygen saturation below 94 lasting more than 3 days and Gr 2 – pts with mild course of COVID-19 who do not who did not meet the eligibility criteria for Group 1. In pts, in the post-COVID period (mean 12±6 weeks an standard 12-lead ECG (ECG) and 24-h Holter ECG (Holter) were performed. Following parameters were analysed in ECG: mean heart rate (mHR); PQ interval (PQ), QRS duration (QRSd); corrected QT interval (QTc); atrial fibrillation (AF); inappropriate sinus tachycardia (ITS), QRS duration > 120ms (QRS>120); LBBB, RBBB, QRS fragmentation (QRSf); STT wave abnormalities (STTabn); presence of premature supraventricular (SVES) and ventricular (VES) complexes; in 24-h Holter ECG: sinus tachycardia (STach), new atrial fibrillation (AFHolter), SVES > 1000/24h (SVES>1000); supraventricular tachycardia (TSV), VES > 1000/24h (VES>1000), Couplet VES (VEScouplet), non-sustained sustained tachycardia (nsVT); ventricular tachycardia (VT), block A-V 2nd typ 2 and/or block A-V 3rd grade (AVdist). Next, all above parameters were compared between both groups. RESULTS: A total of 1032 patients, (64% women and 36% men), mean age was 47.8± 16.5 were included in the analysis., of whom 336 pts (32,5%) had severe course of COVID-19. There was no significant differences in all except the number of nsVT which were significant more frequent in pts with severe course of COVID-19. (Gr 1 0,056 ±0,482 vs Gr 2=0,007±0,085; p=0,024). In no one pts VT and or VF was found. Results regarding number of pts in both groups and ecg abnormalities and cardiac arrhythmias are summarized in Table 1. Multivariate regression analysis showed that age (RR 1.012, 95%CL 1.002-1.024 p=0,02) and nsVT (RR 3,328 95%CL 1.057-10.481 p=0,039) are significantly related to severe course of non hospitalised COVID-19 pts. CONCLUSIONS: Atrial Fibrillation and nsVT episodes occurred significant more frequent in non hospitalised pts with COVID-19 without history of cardiovascular disease in severe course of disease but in small percentage of pts. Age and episodes of nsVT are significantly related to the severity of COVID-19 in non hospitalised pts with no history of cardiovascular disease. [Figure: see text]
format Online
Article
Text
id pubmed-10207495
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102074952023-05-25 Does the severity of the course of COVID-19 in pts without hospitalization and no history of cardiovascular disease affect of cardiac arrhythmias Chudzik, M Babicki, M Kapusta, J Kolat, D Kaluzinska-Kolat, Z Mastalerz-Migas, A Jankowski, P Europace 9.6 - Clinical FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Many studies have shown that arrhythmias are an independent risk factor for death and the course of COVID-19 in these pts. However, there are no data on the impact of the SARS CoV-2 virus on pts with a domestic course of COVID-19 without a previous history of cardiovascular disease. The aim of the study was to assess whether the severity of the home course of COVID-19 has an impact on cardiac arrhythmias in pts without previous cardiovascular disease. METHODS: The study included only pts after COVID-19 without hospitalization, without previous cardiovascular disease. Pts were divided into two groups depending on the severity of the COVID-19 course: Gr 1 with severe course of disease: symptoms lasting 7, dyspnoea lasting with oxygen saturation below 94 lasting more than 3 days and Gr 2 – pts with mild course of COVID-19 who do not who did not meet the eligibility criteria for Group 1. In pts, in the post-COVID period (mean 12±6 weeks an standard 12-lead ECG (ECG) and 24-h Holter ECG (Holter) were performed. Following parameters were analysed in ECG: mean heart rate (mHR); PQ interval (PQ), QRS duration (QRSd); corrected QT interval (QTc); atrial fibrillation (AF); inappropriate sinus tachycardia (ITS), QRS duration > 120ms (QRS>120); LBBB, RBBB, QRS fragmentation (QRSf); STT wave abnormalities (STTabn); presence of premature supraventricular (SVES) and ventricular (VES) complexes; in 24-h Holter ECG: sinus tachycardia (STach), new atrial fibrillation (AFHolter), SVES > 1000/24h (SVES>1000); supraventricular tachycardia (TSV), VES > 1000/24h (VES>1000), Couplet VES (VEScouplet), non-sustained sustained tachycardia (nsVT); ventricular tachycardia (VT), block A-V 2nd typ 2 and/or block A-V 3rd grade (AVdist). Next, all above parameters were compared between both groups. RESULTS: A total of 1032 patients, (64% women and 36% men), mean age was 47.8± 16.5 were included in the analysis., of whom 336 pts (32,5%) had severe course of COVID-19. There was no significant differences in all except the number of nsVT which were significant more frequent in pts with severe course of COVID-19. (Gr 1 0,056 ±0,482 vs Gr 2=0,007±0,085; p=0,024). In no one pts VT and or VF was found. Results regarding number of pts in both groups and ecg abnormalities and cardiac arrhythmias are summarized in Table 1. Multivariate regression analysis showed that age (RR 1.012, 95%CL 1.002-1.024 p=0,02) and nsVT (RR 3,328 95%CL 1.057-10.481 p=0,039) are significantly related to severe course of non hospitalised COVID-19 pts. CONCLUSIONS: Atrial Fibrillation and nsVT episodes occurred significant more frequent in non hospitalised pts with COVID-19 without history of cardiovascular disease in severe course of disease but in small percentage of pts. Age and episodes of nsVT are significantly related to the severity of COVID-19 in non hospitalised pts with no history of cardiovascular disease. [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207495/ http://dx.doi.org/10.1093/europace/euad122.771 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 9.6 - Clinical
Chudzik, M
Babicki, M
Kapusta, J
Kolat, D
Kaluzinska-Kolat, Z
Mastalerz-Migas, A
Jankowski, P
Does the severity of the course of COVID-19 in pts without hospitalization and no history of cardiovascular disease affect of cardiac arrhythmias
title Does the severity of the course of COVID-19 in pts without hospitalization and no history of cardiovascular disease affect of cardiac arrhythmias
title_full Does the severity of the course of COVID-19 in pts without hospitalization and no history of cardiovascular disease affect of cardiac arrhythmias
title_fullStr Does the severity of the course of COVID-19 in pts without hospitalization and no history of cardiovascular disease affect of cardiac arrhythmias
title_full_unstemmed Does the severity of the course of COVID-19 in pts without hospitalization and no history of cardiovascular disease affect of cardiac arrhythmias
title_short Does the severity of the course of COVID-19 in pts without hospitalization and no history of cardiovascular disease affect of cardiac arrhythmias
title_sort does the severity of the course of covid-19 in pts without hospitalization and no history of cardiovascular disease affect of cardiac arrhythmias
topic 9.6 - Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207495/
http://dx.doi.org/10.1093/europace/euad122.771
work_keys_str_mv AT chudzikm doestheseverityofthecourseofcovid19inptswithouthospitalizationandnohistoryofcardiovasculardiseaseaffectofcardiacarrhythmias
AT babickim doestheseverityofthecourseofcovid19inptswithouthospitalizationandnohistoryofcardiovasculardiseaseaffectofcardiacarrhythmias
AT kapustaj doestheseverityofthecourseofcovid19inptswithouthospitalizationandnohistoryofcardiovasculardiseaseaffectofcardiacarrhythmias
AT kolatd doestheseverityofthecourseofcovid19inptswithouthospitalizationandnohistoryofcardiovasculardiseaseaffectofcardiacarrhythmias
AT kaluzinskakolatz doestheseverityofthecourseofcovid19inptswithouthospitalizationandnohistoryofcardiovasculardiseaseaffectofcardiacarrhythmias
AT mastalerzmigasa doestheseverityofthecourseofcovid19inptswithouthospitalizationandnohistoryofcardiovasculardiseaseaffectofcardiacarrhythmias
AT jankowskip doestheseverityofthecourseofcovid19inptswithouthospitalizationandnohistoryofcardiovasculardiseaseaffectofcardiacarrhythmias